BioNTech To Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform And Manufacturing Facility In Gaithersburg, MD; Financial Terms Not Disclosed
Deal strengthens BioNTech's cell therapy pipeline by accelerating individualized solid tumor Neoantigen TCR cell therapy research and development program and adding manufacturing footprint in North America
Kite